Table 7.
Country | Study year | Gender | Na | Sampling methodology | Sample type | ICC
|
Reference | ||
---|---|---|---|---|---|---|---|---|---|
ng/mL | ng/mL- SG | ng/mg | |||||||
Belgium | 2012 | Men & women | 8 | All voids over four (baseline) days | Spot | 0.15 | – | 0.26 | Koch et al. (2014) |
24-h | 0.15 | – | 0.28 | ||||||
Canada | 2009–2010 | Women | 80 | Two spot & two 24-h samples during pregnancy & one spot post-partum | Spot | 0.06 | 0.05 | – | Fisher et al. (2015) |
24-hb | 0.32 | 0.32 | – | ||||||
China | 1997–2006 | Men & women | 100 | Three spot samples between 0 and 9 years apart | Spot (M)c | 0.32 | – | 0.25 | Engel et al. (2014) |
Spot (F) | 0.07 | – | 0.13 | ||||||
Denmark | 2008 | Men | 33 | Two spot, three FMV, & three 24-h samples over three months | FMV | 0.10 | – | – | Lassen et al. (2013) |
Spot | 0.42 | – | – | ||||||
24-h | 0.26 | – | 0.26 | ||||||
Netherlands | 2004–2006 | Women | 80 | Three spot samples during pregnancy | Spot | 0.32 | – | 0.31 | Jusko et al. (2014) |
Norway | 2007–2008 | Women | 30 | Three spot samples during pregnancy | Spot | 0.36 | – | 0.13 | Guidry et al. (2015) |
Puerto Rico | 2010–2012 | Women | 105 | Three spot samples during pregnancy | Spot | 0.27 | 0.24 | – | Meeker et al. (2013) |
United States | 1996–2001 | Women | 80 | Two FMVs between 1 and 3 yrs. apart | FMV | – | – | 0.15 | Townsend et al. (2013) |
United States | 2003–2006 | Women | 389 | Two spot samples during pregnancy & one after birth | Spot | 0.25 | – | 0.10 | Braun et al. (2011) |
United States | 2004–2009 | Women | 137 | Two or more spot samples before and during pregnancy | Spot | – | 0.23e | – | Braun et al. (2012) |
United States | 2005–2007 | Women | 143 | Three to five spot samples over two months | Spot | 0.04 | – | 0.04 | Pollack et al. (2016) |
United States | 2005–2008 | Women | 71 | Three spot samples during pregnancy | Spot | 0.23 | 0.11 | 0.14 | Philippat et al. (2013) |
United States | 1992–2007d | Women | 90 | Two to three FMVs 1 and 3 yrs. apart | FMV | 0.09 | – | –f | Reeves et al. (2014) |
United States | 2012 | Men & women | 83 | Seven FMVs for one week (males) | FMV | 0.15 | – | – | Cox et al. (2016) |
14–18 FMVs for two weeks (females) | FMV | ||||||||
United Statesg | 2009–2011 | Men & women | 50 | Six spots (FMVs and bedtime) & six 24-h samples over a six-week period | FMV | 0.09 | 0.09 | 0.12 | This study |
Bedtime | 0.17 | 0.25 | 0.28 | ||||||
24-h | 0.17 | 0.22 | 0.24 |
Number of adults.
Combined data for samples collected on both weekdays and weekends.
Data for 50 males (M) and 50 female (F) reported separately.
These data are from the Women Health Initiative conducted between 1992 and 2007. Data were taken on year 1 and 3 to compare urine data results.
Before pregnancy samples, only.
Authors reported similar ICCs estimates for creatinine-adjusted values as unadjusted values (ICC = 0.09) in this study, but actual data not provided.
Data shown for only ICC estimates over six-weeks, only.